Clinical Trial

Hydrolysed Rice Formula Study

Recruiting
View on ClinicalTrials.gov →
Summary
This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-23; most recent amendment 2026-04-09.
Trial Details
NCT Number NCT06288503
Lead Sponsor Nutricia UK Ltd
Conditions Cow's Milk Protein Allergy
Enrollment 86 participants
Start Date 2024-02-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-13